By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Auriga Laboratories, Inc. 

5555 Triangle Parkway
Suite 300
Norcross  Georgia  30092  U.S.A.
Phone: 877-287-4428 Fax: 678-282-1700


SEARCH JOBS


Industry
Pharmaceutical






Company News
A.T.S. Pharmaceuticals, a Division of Auriga Laboratories, Inc. (ARGA.OB), Launches Breze(TM) Pads for the Topical Treatment of Acne Vulgaris 4/1/2008 8:53:44 AM
Auriga Laboratories, Inc. (ARGA.OB) Announces the Launch of Extendryl┬«(R) PEM and Extendryl(R) GCP 3/21/2008 8:48:38 AM
Auriga Laboratories, Inc. (ARGA.OB) Announces FDA Approval of Liquadd(TM) Oral Solution for the Treatment of ADHD and Upcoming Product Launch 3/10/2008 6:46:37 AM
Frank R. Greico Named CEO of Auriga Laboratories, Inc. (ARGA.OB) 1/24/2008 3:44:56 PM
Auriga Laboratories, Inc. (ARGA.OB) Signs Co-Promotion Agreement With MiddleBrook Pharmaceuticals, Inc. for Keflex(R) 750 mg 1/7/2008 10:02:03 AM
Auriga Laboratories, Inc. (ARGA.OB) Obtains Rights to Market and Sell a New Product Indicated for the Treatment of ADHD 12/3/2007 11:56:36 AM
Auriga Laboratories, Inc. (ARGA.OB) Issues Third Quarter 2007 Dispensed Prescriptions Update on Promoted Products 11/2/2007 11:36:46 AM
Auriga Laboratories, Inc. (ARGA.OB)'s Continues Sale Force Expansion to Position for 2008 10/23/2007 6:34:42 AM
Auriga Laboratories, Inc. (ARGA.OB) to Announce Third Quarter Financial Results on Thursday, November 8th 10/16/2007 11:01:58 AM
Auriga Laboratories, Inc. (ARGA.OB) To Present at America's Growth Capital's 4th Annual Emerging Growth Conference on Thursday, September 20th 9/10/2007 11:38:06 AM
12345678
//-->